NIT
EDIT icon

NumerixS Investment Technologies’s Editas Medicine EDIT Stock Holding History

NumerixS Investment Technologies’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-16,300
Closed -$483K – 1070
2019
Q4 		$483K Buy
16,300
+13,250
+434% +$331K 0.1% 243
2019
Q3 		$69K Sell
3,050
-1,150
-27% -$28.5K 0.02% 652
2019
Q2 		$104K Sell
4,200
-7,600
-64% -$181K 0.03% 590
2019
Q1 		$278K Buy
11,800
+2,720
+30% +$61.6K 0.04% 557
2018
Q4 		$188K Buy
9,080
+3,680
+68% +$100K 0.06% 367
2018
Q3 		$175K Buy
5,400
+399
+8% +$12.9K 0.03% 630
2018
Q2 		$179K Sell
5,001
-599
-11% -$21.2K 0.04% 548
2018
Q1 		$183K Buy
+5,600
New +$200K 0.05% 435
2017
Q4 		– Sell
-25,400
Closed -$610K – 1186
2017
Q3 		$610K Buy
25,400
+8,290
+48% +$158K 0.14% 183
2017
Q2 		$287K Buy
+17,110
New +$308K 0.04% 507

Other funds holding EDIT

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

NumerixS Investment Technologies's EDIT Position: Q1 2020 in Review

NumerixS Investment Technologies sold out of Editas Medicine (EDIT) in Q1 2020, closing a stake of 16,300 shares — an estimated $483K sold.

NumerixS Investment Technologies first reported a position in EDIT in Q2 2017 and held it in 10 quarters. The position peaked at $610K in Q3 2017. 199 funds tracked by Wall St. Rank hold EDIT as of Q1 2020.

  • NumerixS Investment Technologies reported no remaining Editas Medicine position as of Q1 2020 after selling out during the quarter.
  • NumerixS Investment Technologies sold 16,300 Editas Medicine shares in Q1 2020, an estimated $483K.
  • NumerixS Investment Technologies first reported a position in Editas Medicine in Q2 2017 and held it in 10 quarters.
  • NumerixS Investment Technologies's Editas Medicine position peaked at $610K in Q3 2017.
  • 199 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2020.

Based on NumerixS Investment Technologies's 13F filing for Q1 2020, filed 15 May 2020.